March 5, 2020 / 12:23 PM / in a month

BRIEF-BioCryst Begins Proof Of Concept Trial In PNH Patients With Oral Factor D Inhibitor, BCX9930

March 5 (Reuters) - BioCryst Pharmaceuticals Inc:

* BIOCRYST BEGINS PROOF OF CONCEPT TRIAL IN PNH PATIENTS WITH ORAL FACTOR D INHIBITOR, BCX9930

* BIOCRYST PHARMACEUTICALS INC - EXPECTS TO REPORT DATA FROM PROOF OF CONCEPT STUDY IN PNH PATIENTS IN Q2 OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below